Trevena, Inc. Profile Avatar - Palmy Investing

Trevena, Inc.

Trevena, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel medicines for patients affected by central nervous system disorders. Its lead product candidates include OLINVYK (Oliceridine) injection, a G protein bi…

Biotechnology
US, Chesterbrook [HQ]
Strategy & Leadership

Officers & BofD Beta

  • Form 3/4/5
  • Proxy DEF-14A

Total Compensation

- No data, only available if we have DEF 14A compensations in place -
Officers
Name & Position Research Last Appearance
- No data available -
Board of Directors (BofD)
Name & Position Research Last Appearance
- No data available -
End of TRVN's Analysis
CIK: 1429560 CUSIP: 89532E109 ISIN: US89532E2081 LEI: - UEI: -
Secondary Listings
TRVN has no secondary listings inside our databases.